News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dhingra Kapil
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/17/2023 |
4
| Dhingra Kapil (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.82, valued at
$30k
|
|
| 04/04/2023 |
4
| Dhingra Kapil (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 25,200 options to buy
@ $17.66, valued at
$445k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Dhingra Kapil (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 16,500 options to buy
@ $18.26, valued at
$301.3k
|
|
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Dhingra Kapil (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 25,000 options to buy
@ $37.99, valued at
$949.8k
Disposed/sold 10,000 options to buy
@ $29.8, valued at
$298k
Disposed/sold 10,000 options to buy
@ $17.27, valued at
$172.7k
Disposed/sold 15,000 options to buy
@ $6.09, valued at
$91.4k
Disposed/sold 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Dhingra Kapil (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 29,842 options to buy
@ $27.45, valued at
$819.2k
|
|
| 01/22/2021 |
3
| Dhingra Kapil (Director) has filed a Form 3 on Black Diamond Therapeutics, Inc. |
| 12/09/2020 |
4
| Dhingra Kapil (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 24,675 shares
@ $45.09, valued at
$1.1M
Sold 13,523 shares
@ $46.22, valued at
$625k
Sold 1,802 shares
@ $47.04, valued at
$84.8k
Exercised 40,000 options to buy
@ $1.75, valued at
$70k
|
|
| 05/15/2020 |
4
| Dhingra Kapil (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Granted 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 04/02/2020 |
4
| Dhingra Kapil (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 16,500 options to buy
@ $9.78, valued at
$161.4k
|
|
| 06/12/2019 |
4
| Dhingra Kapil (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 15,000 options to buy
@ $6.09, valued at
$91.4k
|
|
| 04/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2018 |
4
| Dhingra Kapil (Director) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 13,500 options to buy
@ $15, valued at
$202.5k
|
|
| 07/19/2018 |
3
| Dhingra Kapil (Director) has filed a Form 3 on Replimune Group, Inc. |
| 05/14/2018 |
4
| Dhingra Kapil (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 10,000 options to buy
@ $17.27, valued at
$172.7k
|
|
| 05/12/2017 |
4
| Dhingra Kapil (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 10,000 options to buy
@ $29.8, valued at
$298k
|
|
| 05/23/2016 |
4
| Dhingra Kapil (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC |
| 06/27/2011 |
4
| Dhingra Kapil (Director) has filed a Form 4 on MICROMET, INC.|
Txns:
| Granted 25,000 options to buy
@ $5.53, valued at
$138.3k
|
|
| 06/24/2010 |
4
| Dhingra Kapil (Director) has filed a Form 4 on MICROMET, INC.|
Txns:
| Granted 15,000 options to buy
@ $6.89, valued at
$103.4k
|
|
| 06/19/2009 |
4
| Dhingra Kapil (Director) has filed a Form 4 on MICROMET, INC. |
| 02/24/2009 |
4
| Dhingra Kapil (Director) has filed a Form 4 on MICROMET, INC. |
| 02/24/2009 |
3
| Dhingra Kapil (Director) has filed a Form 3 on MICROMET, INC. |
|
|